Primary care for persons who inject drugs

Adam J. Visconti, Jarrett Sell, Aaron David Greenblatt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

More than 750,000 persons in the United States inject opioids, methamphetamine, cocaine, or ketamine, and that number is increasing because of the current opioid epidemic. Persons who inject drugs (PWID) are at higher risk of infectious and non-infectious skin, pulmonary, cardiac, neurologic, and other causes of morbidity and mortality. Nonjudgmental inquiries about current drug use can uncover information about readiness for addiction treatment and identify modifiable risk factors for complications of injection drug use. All PWID should be screened for human immunodeficiency virus infection, latent tuberculosis, and hepatitis B and C, and receive vaccinations for hepatitis A and B, tetanus, and pneumonia if indicated. Pre-exposure prophylaxis for human immunodeficiency virus infection should also be offered. Naloxone should be prescribed to those at risk of opioid overdose. Skin and soft tissue infections are the most common medical complication in PWID and the top reason for hospitalization in these patients. Signs of systemic infection require hospitalization, blood cultures, and a comprehensive history and physical examination to determine the source of infection. PWID have a higher incidence of community-acquired pneumonia and are at risk of other pulmonary complications, including opioid-associated pulmonary edema, asthma, and foreign body granulomatosis. Infectious endocarditis is the most common cardiac complication associated with injection drug use and more often involves the right-sided heart valves, which may not present with heart murmurs or peripheral signs and symptoms, in PWID. Injections increase the risk of osteomyelitis, as well as subdural and epidural abscesses.

Original languageEnglish (US)
Pages (from-to)109-116
Number of pages8
JournalAmerican family physician
Volume99
Issue number2
StatePublished - Jan 1 2019

Fingerprint

Primary Health Care
Pharmaceutical Preparations
Opioid Analgesics
Virus Diseases
Hepatitis B
Injections
Pneumonia
Hospitalization
HIV
Epidural Abscess
Latent Tuberculosis
Heart Murmurs
Lung
Skin
Soft Tissue Infections
Hepatitis A
Methamphetamine
Heart Valves
Tetanus
Ketamine

All Science Journal Classification (ASJC) codes

  • Family Practice

Cite this

Visconti, A. J., Sell, J., & Greenblatt, A. D. (2019). Primary care for persons who inject drugs. American family physician, 99(2), 109-116.
Visconti, Adam J. ; Sell, Jarrett ; Greenblatt, Aaron David. / Primary care for persons who inject drugs. In: American family physician. 2019 ; Vol. 99, No. 2. pp. 109-116.
@article{304d744c192643f396de67fb028e849d,
title = "Primary care for persons who inject drugs",
abstract = "More than 750,000 persons in the United States inject opioids, methamphetamine, cocaine, or ketamine, and that number is increasing because of the current opioid epidemic. Persons who inject drugs (PWID) are at higher risk of infectious and non-infectious skin, pulmonary, cardiac, neurologic, and other causes of morbidity and mortality. Nonjudgmental inquiries about current drug use can uncover information about readiness for addiction treatment and identify modifiable risk factors for complications of injection drug use. All PWID should be screened for human immunodeficiency virus infection, latent tuberculosis, and hepatitis B and C, and receive vaccinations for hepatitis A and B, tetanus, and pneumonia if indicated. Pre-exposure prophylaxis for human immunodeficiency virus infection should also be offered. Naloxone should be prescribed to those at risk of opioid overdose. Skin and soft tissue infections are the most common medical complication in PWID and the top reason for hospitalization in these patients. Signs of systemic infection require hospitalization, blood cultures, and a comprehensive history and physical examination to determine the source of infection. PWID have a higher incidence of community-acquired pneumonia and are at risk of other pulmonary complications, including opioid-associated pulmonary edema, asthma, and foreign body granulomatosis. Infectious endocarditis is the most common cardiac complication associated with injection drug use and more often involves the right-sided heart valves, which may not present with heart murmurs or peripheral signs and symptoms, in PWID. Injections increase the risk of osteomyelitis, as well as subdural and epidural abscesses.",
author = "Visconti, {Adam J.} and Jarrett Sell and Greenblatt, {Aaron David}",
year = "2019",
month = "1",
day = "1",
language = "English (US)",
volume = "99",
pages = "109--116",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "2",

}

Visconti, AJ, Sell, J & Greenblatt, AD 2019, 'Primary care for persons who inject drugs', American family physician, vol. 99, no. 2, pp. 109-116.

Primary care for persons who inject drugs. / Visconti, Adam J.; Sell, Jarrett; Greenblatt, Aaron David.

In: American family physician, Vol. 99, No. 2, 01.01.2019, p. 109-116.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Primary care for persons who inject drugs

AU - Visconti, Adam J.

AU - Sell, Jarrett

AU - Greenblatt, Aaron David

PY - 2019/1/1

Y1 - 2019/1/1

N2 - More than 750,000 persons in the United States inject opioids, methamphetamine, cocaine, or ketamine, and that number is increasing because of the current opioid epidemic. Persons who inject drugs (PWID) are at higher risk of infectious and non-infectious skin, pulmonary, cardiac, neurologic, and other causes of morbidity and mortality. Nonjudgmental inquiries about current drug use can uncover information about readiness for addiction treatment and identify modifiable risk factors for complications of injection drug use. All PWID should be screened for human immunodeficiency virus infection, latent tuberculosis, and hepatitis B and C, and receive vaccinations for hepatitis A and B, tetanus, and pneumonia if indicated. Pre-exposure prophylaxis for human immunodeficiency virus infection should also be offered. Naloxone should be prescribed to those at risk of opioid overdose. Skin and soft tissue infections are the most common medical complication in PWID and the top reason for hospitalization in these patients. Signs of systemic infection require hospitalization, blood cultures, and a comprehensive history and physical examination to determine the source of infection. PWID have a higher incidence of community-acquired pneumonia and are at risk of other pulmonary complications, including opioid-associated pulmonary edema, asthma, and foreign body granulomatosis. Infectious endocarditis is the most common cardiac complication associated with injection drug use and more often involves the right-sided heart valves, which may not present with heart murmurs or peripheral signs and symptoms, in PWID. Injections increase the risk of osteomyelitis, as well as subdural and epidural abscesses.

AB - More than 750,000 persons in the United States inject opioids, methamphetamine, cocaine, or ketamine, and that number is increasing because of the current opioid epidemic. Persons who inject drugs (PWID) are at higher risk of infectious and non-infectious skin, pulmonary, cardiac, neurologic, and other causes of morbidity and mortality. Nonjudgmental inquiries about current drug use can uncover information about readiness for addiction treatment and identify modifiable risk factors for complications of injection drug use. All PWID should be screened for human immunodeficiency virus infection, latent tuberculosis, and hepatitis B and C, and receive vaccinations for hepatitis A and B, tetanus, and pneumonia if indicated. Pre-exposure prophylaxis for human immunodeficiency virus infection should also be offered. Naloxone should be prescribed to those at risk of opioid overdose. Skin and soft tissue infections are the most common medical complication in PWID and the top reason for hospitalization in these patients. Signs of systemic infection require hospitalization, blood cultures, and a comprehensive history and physical examination to determine the source of infection. PWID have a higher incidence of community-acquired pneumonia and are at risk of other pulmonary complications, including opioid-associated pulmonary edema, asthma, and foreign body granulomatosis. Infectious endocarditis is the most common cardiac complication associated with injection drug use and more often involves the right-sided heart valves, which may not present with heart murmurs or peripheral signs and symptoms, in PWID. Injections increase the risk of osteomyelitis, as well as subdural and epidural abscesses.

UR - http://www.scopus.com/inward/record.url?scp=85059917549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059917549&partnerID=8YFLogxK

M3 - Article

C2 - 30633481

AN - SCOPUS:85059917549

VL - 99

SP - 109

EP - 116

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 2

ER -

Visconti AJ, Sell J, Greenblatt AD. Primary care for persons who inject drugs. American family physician. 2019 Jan 1;99(2):109-116.